Media Advisory: Kythera Biopharmaceuticals Announces Preliminary Two-Year Follow-Up Study Results and Poster Presentation of Phase 2B Data from Investigational Fat Reduction Drug at American Society for Dermatologic Surgery

(BUSINESS WIRE)--KYTHERA Biopharmaceuticals, Inc.: What: Oral Presentation of Preliminary Two-Year Long-Term Follow-Up Study Results from Phase 2 Trials with ATX-101 for the Reduction of Localized Fat. Poster Presentation of Results from a Phase 2B Study with ATX-101 Using Investigator, Subject and Magnetic Resonance Imaging Assessments

When: Long-Term Follow-up Study Oral Presentation Friday, November 4, 2011 4:35 PM EDT (1:35 PM PDT, 3:35 PM Central)

Phase 2B Poster Presentation Friday, November 4, 2011 5:30 p.m. EDT (2:30 PM PDT, 4:30 PM Central)